Tag: Diffuse midline glioma research
Enzyme inhibitor shows promise for diffuse midline gliomas
New research shows that stopping the activity of the ACVR1 enzyme could slow tumour growth in diffuse midline gliomas (formerly known as DIPG)
Monitoring diffuse midline gliomas with liquid biopsies
Researchers have found a way to monitor diffuse midline gliomas (formerly known as DIPG) by measuring tumour biomarkers through a blood test
Treating diffuse midline gliomas with an oncolytic virus
Results from a phase 1 clinical trial of the oncolytic virus DNX-2401, report successful intratumoral delivery of the virus in children with diffuse midline glioma
Using CAR-T cell therapy to treat diffuse midline glioma
Recently published research shows that CAR-T cell therapy, a type of immunotherapy, has the ability to treat diffuse midline glioma
Developing a Vaccine to Treat Diffuse Midline Glioma
Researchers at UC San Francisco develop a vaccine to treat diffuse midline glioma by using the patient’s immune system to attack the tumour cells
New research uncovers a molecule that halts DIPG tumour growth
A team of researchers from Northwestern University, USA have identified a molecule that could be used to inhibit the growth of the most fatal paediatric brain tumour, diffuse pontine intrinsic glioma (DIPG).
New biomarker could improve the diagnosis of diffuse gliomas
Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.